aceclidine 14.4 MG/ML Ophthalmic Solution
- RxCUI
- 2721771
- RxNorm name
- aceclidine 14.4 MG/ML Ophthalmic Solution
- Display name
- aceclidine 14.4 MG/ML Ophthalmic Solution
- Full name
- aceclidine 14.4 MG/ML Ophthalmic Solution
- Term type
- SCD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:05
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| VIZZ | ACECLIDINE | LENZ Therapeutics, Inc. | 7aed8024-ad30-44d6-8f3b-63338ad3ce52 | 2026-01-14 | Warnings, Adverse reactions | 2721771 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 7aed8024-ad30-44d6-8f3b-63338ad3ce52 | aceclidine 1.44 % Ophthalmic Solution [PSN] · aceclidine 14.4 MG/ML Ophthalmic Solution [SCD] · aceclidine 1.44 % (as aceclidine hydrochloride 1.75 % ) Ophthalmic Solution [SY] · aceclidine 1.44 % Ophthalmic Solution [SY] | 4 | 6 | These highlights do not include all the information needed to use VIZZ™ safely and effectively. See full prescribing information for VIZZ. VIZZ (aceclidine ophthalmic solution) 1.44%, for topical ophthalmic use Initial U.S. Approval: 2025 | 20260114 |